HIGHLIGHTS
- who: Oligomannose-Coated Liposome as a and colleagues from the Department of Applied Biochemistry, Tokai University, Hiratsuka, Kanagawa, Japan have published the Article: Oligomannose-Coated Liposome as a Novel Adjuvant for the Induction of Cellular Immune Responses to Control Disease Status, in the Journal: (JOURNAL) of 20/06/2013
- how: For in_vivo targeting of APCs the authors used OMLs comprised of dipalmitoylphosphatidylcholine (DPPC) cholesterol and a neoglycolipid containing oligomannose residue at a 10 10 1 molar ratio. To determine whether OMLs could deliver stimulatory signals to APCs the authors evaluated the adjuvant activity of OMLs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.